News | June 17, 2015

Elekta Helps Raise $33,000 to Bring Radiation Treatment to Developing Countries

Fundraising activities at ESTRO to support nonprofit organization, Radiating Hope

Elekta, Radiating Hope, radiation therapy, developing countries, ESTRO

June 17, 2015 - Together with its customers, Elekta raised EUR 30,575 (USD 33,250) during the 3rd European Society for Therapeutic Radiology and Oncology (ESTRO) Forum in Barcelona in April. The funds will be donated to Radiating Hope, a nonprofit organization with the mission to improve cancer care, specifically radiation oncology care, around the world.

Radiating Hope believes that no patient should be denied potentially life-saving treatment simply because the technology is not affordable. Consequently, it cooperates with hospitals and clinics around the world to take care of their replaced equipment, refurbish the machine and then ship it to a developing country.

President and co-founder of the organization, Dr. Brandon Fisher, says: "While I was a radiation oncology resident, I did a medical mission in Africa and discovered that such missions in radiation therapy were almost nonexistent. I wanted to change that."

Elekta and Radiating Hope used the ESTRO Forum to strengthen their partnership agreement, which will see Elekta making an increased commitment to giving people in developing countries access to radiation therapy. The partners also discussed how to advance the role of education and training in countries where the equipment might exist, but not the clinical experience.

For more information: www.elekta.com

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...